Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ
P-glycoprotein (P-gp) is a trans-membrane drug efflux pump. Several drugs are P-gp substrates. Some drugs may affect the activity of P-gp by inhibiting its function, resulting in significant drug-drug interactions (DDIs). It is critical to understand which drugs are inhibitors of P-gp so that advers...
Saved in:
Main Authors: | Mehran Mesgari Abbasi (Author), Hadi Valizadeh (Author), Hamed Hamishehkar (Author), Parvin Zakeri-Milani (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro and in situ effects of atorvastatin and ezetimibe on P-glycoprotein expression and function
by: Mehran Mesgari Abbasi, et al.
Published: (2016) -
The Effects of Cetirizine on P-glycoprotein Expression and Function In vitro and In situ
by: Mehran Mesgari Abbasi, et al.
Published: (2016) -
Multivariate Chemometric Assisted Analysis of Metformin Hydrochloride, Gliclazide and Pioglitazone Hydrochloride in Bulk Drug and Dosage Forms
by: Vipin Saini, et al.
Published: (2013) -
Effects of polyethylene glycols on intestinal efflux pump expression and activity in Caco-2 cells
by: Darya Hodaei, et al.
Published: (2015) -
Valsartan in combination with metformin and gliclazide in diabetic rat model using developed RP-HPLC method
by: Rasmita Patra, et al.
Published: (2021)